The future for parents and families touched by autism
Neuropharm is on track to launch the world’s first drug to treat autism.

Fragile X syndrome: clinical studies now underway
Neuropharm is investigating two separate but potentially complementary drug candidates for the treatment of Fragile X.

Pediatric Obsessive Compulsive Disorder
Learn more about Pediatric OCD and Neuropharm’s Phase II trial of a potentially beneficial product for sufferers of the condition.